SCHEMBL28666355

SCHEMBL28666355

CC(C)(C)C(=O)OC(=O)C1CCCCO1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.40
TSHR P16473 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.34
NPC1 O15118 2/20 0.34
ALDH1A1 P00352 5/20 0.33
KDM4E B2RXH2 2/20 0.33
RAB9A P51151 1/20 0.33
SSTR4 P31391 1/20 0.33
NOS2 P35228 1/20 0.32
CNR2 P34972 1/20 0.32
POLB P06746 1/20 0.32
RECQL P46063 1/20 0.32
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
TP53 P04637 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5046503 0.83 HPGD (0.44) HPGDTSHRNPSR1SMN1; SMN2NPC1
SCHEMBL31343355 0.81 HPGD (0.43) HPGDTSHRNPSR1SMN1; SMN2NPC1
SCHEMBL27725570 0.79 HPGD (0.44) HPGDTSHRNPSR1SMN1; SMN2NPC1
SCHEMBL28075374 0.79 HPGD (0.42) HPGDTSHRNPSR1SMN1; SMN2NPC1
SCHEMBL22076454 0.77 HPGD (0.41) HPGDTSHRNPSR1SMN1; SMN2NPC1
SCHEMBL30135339 0.77 NOS2 (0.46) HPGDTSHRNPSR1SMN1; SMN2NPC1
SCHEMBL9328453 0.77 NOS2 (0.46) HPGDTSHRNPSR1SMN1; SMN2NPC1
SCHEMBL30135380 0.77 NOS2 (0.46) HPGDTSHRNPSR1SMN1; SMN2NPC1
SCHEMBL2200874 0.76 HPGD (0.49) HPGDTSHRNPSR1SMN1; SMN2NPC1
SCHEMBL15113296 0.76 SMN1; SMN2 (0.38) HPGDTSHRNPSR1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113727979-A Novel catecholamine prodrugs for the treatment of parkinson's disease H.隆德贝克有限公司 2021-11-30 CN claimed
CN-113727979-A Novel catecholamine prodrugs for the treatment of parkinson's disease H.隆德贝克有限公司 2021-11-30 CN disclosed